Biotechnology News

July 16, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--A new report from IDC Health Insights highlights the rapid evolution of the health information exchange (HIE) market and evaluates 16 vendors that offer an HIE platform solution.

July 16, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced initial findings from the Riata® Lead Evaluation Study. The study’s phase-one results found that externalized conductors...

July 16, 2012

SAN DIEGO--(BUSINESS WIRE)--Researchers at the University of California San Francisco (UCSF) demonstrated the demonstrated the utility of the Irys™ platform from BioNano Genomics for structural variation analysis and assembly

July 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Galenea Corp., a leader in the rapidly emerging field of synaptic transmission, is pleased to announce the appointment of Timothy Ryan, PhD. to its Scientific Advisory Board. Dr. Ryan is a leading expert on...

July 16, 2012

WALTHAM, Mass. & CANOGA PARK, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to acquire One Lambda, the leader in transplant...

July 16, 2012

LEXINGTON, Ky.--(BUSINESS WIRE)--MedPro Safety Products, Inc. (OTCBB:MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced it has signed a letter of intent with a...

July 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the achievement of positive clinical results from its Phase I trial with ALN-TTR02, an RNAi therapeutic...

July 16, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB publ (STO:ORX) The Board of Orexo AB (“Orexo”) has resolved, within the framework of the authorization to repurchase up to a maximum of 10 percent of the company’s own shares, which was...

July 16, 2012

BRUSSELS & ATLANTA--(BUSINESS WIRE)--UCB announced today that Neupro® (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro® was approved by the U.S. Food and Drug Administration in April to treat the signs and symptoms...

July 14, 2012

MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, is pleased to announce that Suresh Vazirani, Chairman of ERBA Diagnostics, will be a key note speaker at the International Marketing...

July 13, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today presentations at the upcoming Alzheimer’s Association International Conference (AAIC) being held in Vancouver,...

July 13, 2012

JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its second quarter 2012 financial results on Thursday, August 2, 2012 at 7:00 a.m. EDT. Teva will host a conference call and...

July 13, 2012

BOSTON--(BUSINESS WIRE)--Ember Therapeutics Announces Cell Publication of Key Beige Fat Discovery; Technology Licensed from the Dana-Farber Cancer Institute

July 13, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced today that the company has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to submit a full proposal for a Broad Agency...

July 13, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced the closing of a $115 million underwritten...

July 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and collaborators announced today the publication of a scientific paper documenting the discovery of novel lipids used in second...

July 13, 2012

PRINCETON, N.J. & GAINSVILLE, Fla.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc. (OTCQB: QMDT.PK), a life sciences company...

July 13, 2012

LONG BEACH, Calif.--(BUSINESS WIRE)--BioFormatix will release their Bootstrapped Receiver Operating Characteristic (bROC) plug-in for CLC bio's desktop software packages, CLC Main Workbench and CLC Genomics Workbench, this Sunday.

July 13, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTCBB: RXII.OB) today announced the appointment of Dr. Jeannette Graf and Dr. Leroy Young to its Scientific Advisory Board. The addition of these two highly esteemed clinicians...

July 13, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (NYSE: LH) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act...

July 13, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2012 following the close of market on Tuesday, July 24, 2012. On the same day, at 2:00pm Pacific Time (5:00pm Eastern Time) Jay...

July 12, 2012

OWINGS MILLS, Md.--(BUSINESS WIRE)--Univec Moves Forward on Pharmaceutical Transdermal Delivery

July 12, 2012

LYON, France--(BUSINESS WIRE)--Regulatory News: The MEDICREA Group (FR0004178572-ALMED), listed on Alternext by NYSE - Euronext Paris, a company specialized in the development of innovative surgical technologies for the treatment of spinal...

July 12, 2012

MADISON, Wis.--(BUSINESS WIRE)--Two of the nation’s top life science CEOs set to keynote BioForward’s 25th Annual Bioscience Vision Summit

July 12, 2012

SEATTLE--(BUSINESS WIRE)--July 12, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced that management will host a conference call on Monday, July 30, 2012, at 4:30 p.m. ET to review second quarter financial results. Access to the discussion...

July 12, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, July 25, 2012 at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British Summer Time (BST) with the investment community to...

July 12, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.13 per share. The dividend will be paid on...

July 12, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has rescheduled its annual meeting of stockholders to Tuesday, July 31, 2012, at 2:00...

July 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--IntegraGen announced today that the company has received €2 million in financing from funds managed by A Plus Finance to support development and marketing of genetic tests for autism and oncology.

July 12, 2012

NEW YORK CITY--(BUSINESS WIRE)--The James J. Peters Veterans Hospital in Bronx, New York, is actively recruiting participants for a phase IIb clinical trial testing NIC5-15, a disease modifying candidate for Alzheimer’s disease.

July 12, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase...

July 12, 2012

ZURICH & LUGANO, Switzerland--(BUSINESS WIRE)--The winners of the Fidelity Future Impact Prize were announced on Monday at the inaugural Partnering for Global Impact conference in Lugano, Switzerland. Sponsored by Fidelity Worldwide...

July 12, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces two key achievements in...

July 12, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its second quarter 2012 financial results at 4:00 p.m. ET on Thursday, July 19th, 2012. In connection with this announcement, Cubist will host a conference...

July 12, 2012

WASHINGTON--(BUSINESS WIRE)--Six biofuel trade organizations jointly petitioned the U.S. Court of Appeals for the District of Columbia Circuit to intervene with EPA in a lawsuit filed by petroleum refiners over the RFS

July 12, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the fourth patient, the first in the second patient cohort, in its U.S....

July 12, 2012

WASHINGTON--(BUSINESS WIRE)--Ohio's bioscience industry organization to update state's Congressional delegation on growth, opportunities, and challenges

July 12, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN) announced today that it has priced an underwritten public offering of 6.25 million shares of its common stock at a price to the public of $16 per share. Gross proceeds are expected...

July 12, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Rex Health Ventures, one of the nation’s only venture-capital funds managed by a community, nonprofit hospital, is pleased to announce its first investment, a $500,000 equity placement in Aerial BioPharma. Aerial,...

July 12, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the Seventh Annual JMP...

July 12, 2012

DANVERS, Mass.--(BUSINESS WIRE)--NeuroLogica Corporation and Medtronic Surgical Technologies, a business unit of Medtronic Inc, announced the integration NeuroLogica’s portable BodyTomTM 32-slice CT scanner with Medtronic’s StealthStation® S7®...

July 12, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega announces PowerPlex(R) Y23 System, a human identification Y-STR assay for forensic casework, offender databasing and relationship testing.

July 12, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced the opening of its Global Commercial Solutions business in Brazil, offering customized sales forces, market penetration strategies and product solutions.

July 12, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its third quarter of fiscal year...

July 12, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the initiation of its pivotal Phase 3 studies evaluating the efficacy and safety of CB-315 in patients with Clostridium difficile-associated diarrhea,...

July 12, 2012

CAMBRIDGE, Mass. & HANGZHOU, China & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Ascletis Pharmaceuticals (Hangzhou) Co., Ltd.., a privately held US...

July 12, 2012

DEERFIELD, Ill. & PALO ALTO, Calif.--(BUSINESS WIRE)--Takeda Pharmaceuticals U.S.A. (TPUSA) and Affymax, Inc. (Nasdaq:AFFY) today announced that Takeda Pharmaceuticals America, Inc. (TPA) has entered into a supply agreement for sourcing and...

July 12, 2012

EXTON, Penn.--(BUSINESS WIRE)--According PatientTrends®: Crohn’s Disease, 13 percent of Crohn’s patients report requesting specific brands of Crohn’s medications for their disease treatment from their gastroenterologists.

July 12, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced top-line results from the PALACE-1 study, the first of three pivotal phase III, randomized, placebo-controlled...